TRPC6 Gene Focal Segmental Glomerulosclerosis Type 2 Genetic Test
At DNA Labs UAE, we offer the TRPC6 Gene Focal Segmental Glomerulosclerosis (FSGS) Type 2 Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the TRPC6 Gene Focal Segmental Glomerulosclerosis Type 2 Genetic Test, it is important to provide the clinical history of the patient. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with TRPC6 Gene Focal Segmental Glomerulosclerosis Type 2 NGS Genetic DNA Test gene TRPC6.
Test Details
The TRPC6 gene is associated with focal segmental glomerulosclerosis (FSGS) type 2, a kidney disorder characterized by scarring of the glomeruli in the kidneys. This condition can lead to proteinuria (excessive protein in the urine) and progressive kidney damage.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations. In the context of FSGS type 2, NGS genetic testing can be used to identify mutations or variations in the TRPC6 gene that may be causing or contributing to the development of the disease.
By identifying specific genetic variants in the TRPC6 gene, NGS genetic testing can help with the diagnosis of FSGS type 2 and provide valuable information for personalized treatment and management strategies. It can also help in identifying individuals who may be at risk of developing FSGS type 2 due to inherited genetic mutations.
NGS genetic testing is typically performed using a blood or saliva sample, and the results are analyzed by genetic specialists or genetic counselors. It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and discuss any further steps or treatment options.
Test Name | TRPC6 Gene Focal segmental glomerulosclerosis type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TRPC6 Gene Focal segmental glomerulosclerosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRPC6 Gene Focal segmental glomerulosclerosis type 2 NGS Genetic DNA Test gene TRPC6 |
Test Details |
The TRPC6 gene is associated with focal segmental glomerulosclerosis (FSGS) type 2, a kidney disorder characterized by scarring of the glomeruli in the kidneys. FSGS can lead to proteinuria (excessive protein in the urine) and progressive kidney damage. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations. In the context of FSGS type 2, NGS genetic testing can be used to identify mutations or variations in the TRPC6 gene that may be causing or contributing to the development of the disease. By identifying specific genetic variants in the TRPC6 gene, NGS genetic testing can help with the diagnosis of FSGS type 2 and provide valuable information for personalized treatment and management strategies. It can also help in identifying individuals who may be at risk of developing FSGS type 2 due to inherited genetic mutations. NGS genetic testing is typically performed using a blood or saliva sample, and the results are analyzed by genetic specialists or genetic counselors. It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and discuss any further steps or treatment options. |